Tehranian, N., Sepehri, H., Biramijamal, F., Mehdipour, P., Hossein-Nezhad, A., Sarrafnejad, A., Hajizadeh, E. & Delphi, L. (2020). The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines. Daneshvar Medicine, 19(4), 65–78.

Tehranian, N., Sepehri, H., Biramijamal, F., Mehdipour, P., Hossein-Nezhad, A., Sarrafnejad, A., Hajizadeh, E., & Delphi, L. "The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines", Daneshvar Medicine, 19, 4, 2020, 65–78.

Tehranian, N., Sepehri, H., Biramijamal, F., Mehdipour, P., Hossein-Nezhad, A., Sarrafnejad, A., Hajizadeh, E., & Delphi, L. (2020). 'The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines', Daneshvar Medicine, 19(4), pp. 65–78.

Tehranian, N., Sepehri, H., Biramijamal, F., Mehdipour, P., Hossein-Nezhad, A., Sarrafnejad, A., Hajizadeh, E. & Delphi, L., "The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines." Daneshvar Medicine, 19 4 (2020): 65–78,

Tehranian N., Sepehri H., Biramijamal F., Mehdipour P., Hossein-Nezhad A., Sarrafnejad A., Hajizadeh E., Delphi L. The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines. Daneshvar Med. 2020;19(4):65–78 (In Persian).